ATHE
Alterity Therapeutics Limited
NASDAQ · Healthcare · Biotechnology · AU
$4.54
+0.44%Margins
Gross margin
95.5%
EBITDA margin
-789.0%
EBIT margin
-790.1%
Net margin
-653.9%
FCF margin
-197.0%
-83.2%
Return on equity
-77.3%
Return on assets
-100.1%
Return on invested capital
0.11x
Asset turnover
-$24.4M
Cash from operations
$1.48
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026